The Outcomes and Quality of Pancreatic Islet Cells Isolated from Surgical Specimens for Research on Diabetes Mellitus

Cells. 2022 Jul 29;11(15):2335. doi: 10.3390/cells11152335.

Abstract

Isolating a large quantity of high-quality human islets is a prerequisite for diabetes research. Human islets are typically isolated from the pancreases of brain-dead donors, making research difficult due to low availability. Pancreas tissue discarded after surgical resection may be a good alternative source of islet cells. To test this hypothesis, we isolated islets from discarded surgical specimens and evaluated the islet yield and quality as well as islet cell preparations. Eighty-two segmental pancreases were processed using the Ricordi automated method, and islet yield and quality were investigated. The mean age of patients was 54.6, and the cohort included 32 diabetes patients. After purification, partially resected pancreases yielded an average of 59,593 ± 56,651 islet equivalents (IEQs) and 2546 IEQ/g of digested pancreas, with 71.5 ± 21% purity. Multivariate analysis revealed that diabetes (p = 0.0046) and the lobe used (p = 0.0156) significantly altered islet yield. Islets transplanted into diabetic mice displayed good viability and in vitro glucose responses, DNA/RNA quality, mitochondrial function, and glucose control, even though these results were dependent on islet quality. Isolated cells also maintained high viability and function even after cryopreservation. Our findings indicate that pancreatic tissue discarded after surgery can be a valuable source of islets for diabetes research.

Keywords: diabetes; human islet isolation; pancreatic islet; partial pancreas; surgical specimens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental*
  • Humans
  • Islets of Langerhans Transplantation* / methods
  • Islets of Langerhans*
  • Mice
  • Pancreas
  • Tissue Donors

Grants and funding

This work was supported by the Alchemist Project (20012378, Development of Meta Soft Organ Module Manufacturing Technology without Immunity Rejection and Module Assembly Robot System), the Ministry of Trade, Industry & Energy (MOTIE, Korea). This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government Ministry of Science and ICT (MSIT) (No. 2021R1I1A2048392). This study was supported by a grant (No. 2021IP0018-1) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. This research was supported by the Korean Fund for Regenerative Medicine funded by the Ministry of Science and ICT and the Ministry of Health and Welfare (RS-2022-00080258, Republic of Korea).